Publication | Open Access

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

UrologySurgical OncologyGenitourinary CancerProsper Ecog-acrin Ea8143MedicineKidney FailureRenal Cell CarcinomaSurgeryOncology